课题基金 / 基金详情

GENETIC MARKER--SELECTIVE ATTENTION IN SCHIZOPHRENIA

GENETIC MARKER--SELECTIVE ATTENTION IN SCHIZOPHRENIA
遗传标记——精神分裂症的选择性注意
批准号:
3475223
负责人:
MARINA MYLES-WORSLEY
金额:
$7.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-04-01 至 1994-03-31

项目摘要

项目成果

MARINA MYLES-WORSLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the promising directions in schizophrenia research is the search for genetic markers of the disorder, biologically-based characteristics that identify individuals with a genetic predisposition for schizophrenia. Attention dysfunction is a strong candidate as a genetic marker for schizophrenia because the attentional abnormalities that are a central symptom of acute schizophrenia have been found in both chronic schizophrenics in symptom remission and in children with a schizophrenic parent. However, a measure of this attentional dysfunction that is independent of global processing deficits and specific to schizophrenia is needed. A new visual information processing task that-measures expectation-based selectivity has the potential to fill this gap. The principal objective of the proposed research is to investigate defective attentional selectivity as a potential genetic marker for schizophrenia. We plan to use cognitive and neurophysiological measures of selective attention to phenotype large pedigrees with multiple incidence of schizophrenia in order to determine whether defective selectivity is linked to the same gene(s) that convey risk for schizophrenia. Study 1 will identify that combination of cognitive and neurophysiological measures which optimizes the distinction between normal and abnormal attentional selectivity. Study 2 will use this combination of measures in a longitudinal study to establish that defective selectivity is a trait marker specific to schizophrenia rather than a state- dependent abnormality associated with psychosis. Study 3 will examine ten large families with a high rate of schizophrenia for abnormal attentional selectivity. These families are currently being genotyped for schizophrenia in a study being conducted by Dr. William F. Byerley in collaboration with the Howard Hughes Medical Institute. Defective selectivity will then be investigated as a phenotypic expression of genes transmitting risk for schizophrenia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disruption of an epigenetic locus controlling EAAC1 expression in schizophrenia
  • 批准号:
    8432795
  • 项目类别:
  • 资助金额:
    $11.48万
  • 财政年份:
    2012
  • 负责人:
    MARINA MYLES-WORSLEY
  • 依托单位:
Disruption of an epigenetic locus controlling EAAC1 expression in schizophrenia
  • 批准号:
    8229085
  • 项目类别:
  • 资助金额:
    $31.9万
  • 财政年份:
    2012
  • 负责人:
    MARINA MYLES-WORSLEY
  • 依托单位:
Genetics of Schizophrenia in Oceanic Palau.
  • 批准号:
    7244500
  • 项目类别:
  • 资助金额:
    $57.14万
  • 财政年份:
    2007
  • 负责人:
    MARINA MYLES-WORSLEY
  • 依托单位:
Genetics of Schizophrenia in Oceanic Palau.
  • 批准号:
    7629027
  • 项目类别:
  • 资助金额:
    $28.76万
  • 财政年份:
    2007
  • 负责人:
    MARINA MYLES-WORSLEY
  • 依托单位:
海外基金